Time to take some gains and buy into PATH. GSK has 13.9% ownership
Take some time and do your DD on PATH. Very small float, board meeting next week with news to follow. New FDA product and they are looking for a partnership or buyout. And who owns 13.9% over the past six months? GlaxoSmithKline GSK, that's who. So take some profits and but 1,000 or 2,000 shares to cover. VERY high upside gains with limited downside.